B. Braun adds Plasmat Futura System to H.E.L.P. LDL Apheresis therapy

The Renal Therapies Division of B. Braun Medical Inc. (B. Braun) announced today the availability of the Plasmat™ Futura System for H.E.L.P.®  LDL Apheresis therapy. This addition to B. Braun's existing H.E.L.P.® therapy provides a more easy-to-use system for clinicians to administer the most effective care to patients with severe hypercholesterolemia.

H.E.L.P.®  therapy (Heparin-induced Extracorporeal Lipoprotein Precipitation) is a blood cleansing procedure for the long-term management of patients with severe, congenital lipid disorders that cannot be adequately treated with diet modification or drugs.

"The addition of the Plasmat™ Futura Apheresis system to our existing H.E.L.P.® therapy system exemplifies B. Braun's commitment to providing clinicians with innovative systems that help get their jobs done with more convenience and flexibility," said Samuel Amory, Vice President, Medical Technology Division for B. Braun Medical Inc. "LDL Apheresis therapy is a complex therapy and the Plasmat™ Futura helps to streamline treatment."  

Designed to be compact and easy to use, the Plasmat™ Futura system provides built-in convenience for maximum mobility and flexibility. In addition, the Plasmat™ Futura features a state-of-the-art user interface and does not require an on-site water treatment system, both improvements over the previous H.E.L.P.® system.

"The Plasmat™ Futura LDL Apheresis machine is the first promising procedure that has drastically cut my LDL by more than 60 percent," said Patrika Wallach-Knickle, a patient of Massachusetts General Hospital. "All it requires is a commitment of two mornings a month to sit and relax while the machine does the work. This small commitment is nothing compared to the benefits of seeing my small child grow up. I am very grateful for the B. Braun Plasmat™ Futura LDL Apheresis machine."

Source:

B. Braun Medical Inc.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    B. Braun Melsungen AG. (2019, June 20). B. Braun adds Plasmat Futura System to H.E.L.P. LDL Apheresis therapy. News-Medical. Retrieved on September 17, 2019 from https://www.news-medical.net/news/20110715/B-Braun-adds-Plasmat-Futura-System-to-HELP-LDL-Apheresis-therapy.aspx.

  • MLA

    B. Braun Melsungen AG. "B. Braun adds Plasmat Futura System to H.E.L.P. LDL Apheresis therapy". News-Medical. 17 September 2019. <https://www.news-medical.net/news/20110715/B-Braun-adds-Plasmat-Futura-System-to-HELP-LDL-Apheresis-therapy.aspx>.

  • Chicago

    B. Braun Melsungen AG. "B. Braun adds Plasmat Futura System to H.E.L.P. LDL Apheresis therapy". News-Medical. https://www.news-medical.net/news/20110715/B-Braun-adds-Plasmat-Futura-System-to-HELP-LDL-Apheresis-therapy.aspx. (accessed September 17, 2019).

  • Harvard

    B. Braun Melsungen AG. 2019. B. Braun adds Plasmat Futura System to H.E.L.P. LDL Apheresis therapy. News-Medical, viewed 17 September 2019, https://www.news-medical.net/news/20110715/B-Braun-adds-Plasmat-Futura-System-to-HELP-LDL-Apheresis-therapy.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
B. Braun to become exclusive U.S. distributor of BSmart injection pressure monitor for PNBs